KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Shares Outstanding (Diluted Average): 2011-2024

Historic Shares Outstanding (Diluted Average) for Pacira BioSciences (PCRX) over the last 13 years, with Dec 2024 value amounting to $46.2 million.

  • Pacira BioSciences' Shares Outstanding (Diluted Average) fell 1.17% to $45.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year decrease of 1.17%. This contributed to the annual value of $46.2 million for FY2024, which is 11.03% down from last year.
  • As of FY2024, Pacira BioSciences' Shares Outstanding (Diluted Average) stood at $46.2 million, which was down 11.03% from $52.0 million recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' Shares Outstanding (Diluted Average) peaked at $52.0 million during FY2023, and registered a low of $43.7 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $46.5 million (2022), whereas its average is $48.3 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first grew by 11.69% in 2023, then dropped by 11.03% in 2024.
  • Pacira BioSciences' Shares Outstanding (Diluted Average) (Yearly) stood at $43.7 million in 2020, then increased by 4.46% to $45.6 million in 2021, then climbed by 1.99% to $46.5 million in 2022, then rose by 11.69% to $52.0 million in 2023, then dropped by 11.03% to $46.2 million in 2024.